The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleepapnea and obesity. Zepbound is the first medication ...
Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleepapnea, per a Food and Drug ...
Some results have been hidden because they may be inaccessible to you